Legal piperazine-containing party pills-a new trend in substance misuse

Authors

  • JANIE SHERIDAN,

    Corresponding author
    1. The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand
      School of Pharmacy, The University of Auckland, 85 Park Road, Grafton, Auckland, New Zealand. Tel: +64 9 373 7599 ext 85247. E-mail: j.sheridan@auckland.ac.nz
    Search for more papers by this author
    • 3

      Janie Sheridan, PhD MRPharmS, MPS(NZ) RegPharmNZ Associate Professor of Pharmacy Practice, The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand.

  • RACHAEL BUTLER,

    1. The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand
    Search for more papers by this author
    • 4

      Rachael Butler BA, Research Project Manager, The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand.

  • CHRIS WILKINS,

    1. Centre for Social and Health Outcomes Research and Evaluation, College of Humanities and Social Sciences, Massey University, New Zealand
    Search for more papers by this author
    • 5

      Chris Wilkins PhD, Senior Researcher, Centre for Social and Health Outcomes Research and Evaluation, College of Humanities and Social Sciences, Massey University, New Zealand.

  • BRUCE RUSSELL

    1. The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand
    Search for more papers by this author
    • 6

      Bruce Russell PhD, MRPharmS, Senior Lecturer, The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand.


School of Pharmacy, The University of Auckland, 85 Park Road, Grafton, Auckland, New Zealand. Tel: +64 9 373 7599 ext 85247. E-mail: j.sheridan@auckland.ac.nz

Abstract

In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called ‘legal party pills’ which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as ‘safe' alternatives’ to ‘illicit’ drugs often used in the dance scene such as MDMA and amphetamines. The authors describe the availability and use of these substances in New Zealand, summarize what is known about their effects, and speculate on harm reduction interventions and mechanisms of control and their possible sequelae. The paper provides a timely account of an emerging drug issue of relevance to harm reduction internationally.

Ancillary